김혜림 (한국과학기술연구원(KIST), 연세대학교)님 | 한빛사연구자 > 한빛사

한국과학기술연구원(KIST), 연세대학교

바이오센싱 및 나노바이오물질

최종업데이트 2025.12.19.

Engineering an immune-integrated lung-on-a-chip to reveal TOX-RAGE axis-driven fibrosis and RAGE blockade as a therapeutic strategy
- Nano Converg., Dec 18 2025, 12 (1) | https://doi.org/10.1186/s40580-025-00529-7
- 2025-12
- 바이오·의료융합
- 한빛사논문
The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases
- Proc. Natl. Acad. Sci. USA, Jun 25 2024, 121 (26) | https://doi.org/10.1073/pnas.2319322121
- 2024-06
- 생명과학
- 한빛사논문
Cleavage-Responsive Biofactory T Cells Suppress Infectious Diseases-Associated Hypercytokinemia
- Adv. Sci., First published: 25 June 2022 | https://doi.org/10.1002/advs.202201883
- 2022-06
- 바이오·의료융합
- 한빛사논문
Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm
- Nano Today, Available online 8 April 2021 | https://doi.org/10.1016/j.nantod.2021.101149
- 2021-04
- 바이오·의료융합
- 한빛사논문
PEGylated Nanoparticle Albumin-Bound Steroidal Ginsenoside Derivatives Ameliorate SARS-CoV-2-Mediated Hyper-Inflammatory Responses
- Biomaterials, Available online 14 April 2021, 120827 | https://doi.org/10.1016/j.biomaterials.2021.120827
- 2021-04
- 바이오·의료융합
- 한빛사논문
Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm
- Biomaterials, Available online 23 October 2020, 120389 | https://doi.org/10.1016/j.biomaterials.2020.120389
- 2020-10
- 바이오·의료융합
- 한빛사논문
Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for SARS-CoV-2 patients
- Eur. Resp. J., Published online August 28, 2020 | DOI: 10.1183/13993003.01531-2020
- 2020-08
- 바이오·의료융합
- 한빛사논문
Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia
- Sci. Adv., 24 Jul 2020: eabc1564 | DOI: 10.1126/sciadv.abc1564
- 2020-07
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기